Funding Rounds
Myricx Bio

Myricx Bio Series A (2024, $115M)

Myricx Bio

Antibody-drug conjugate (ADC) payload platform.

View Company Profile

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Series A

Raised Amount: $115.00M

Raised Date: 2024-08-01

Investors